168 related articles for article (PubMed ID: 24756630)
1. Evaluation of liquid and solid culture media for the recovery and enrichment of Burkholderia cenocepacia from distilled water.
Ahn Y; Kim JM; Ahn H; Lee YJ; LiPuma JJ; Hussong D; Cerniglia CE
J Ind Microbiol Biotechnol; 2014 Jul; 41(7):1109-18. PubMed ID: 24756630
[TBL] [Abstract][Full Text] [Related]
2. Oligotrophic Media Compared with a Tryptic Soy Agar or Broth for the Recovery of
Ahn Y; Lee UJ; Lee YJ; LiPuma JJ; Hussong D; Marasa B; Cerniglia CE
J Microbiol Biotechnol; 2019 Oct; 29(10):1495-1505. PubMed ID: 31434364
[TBL] [Abstract][Full Text] [Related]
3. Survival and susceptibility of Burkholderia cepacia complex in chlorhexidine gluconate and benzalkonium chloride.
Kim JM; Ahn Y; LiPuma JJ; Hussong D; Cerniglia CE
J Ind Microbiol Biotechnol; 2015 Jun; 42(6):905-13. PubMed ID: 25794566
[TBL] [Abstract][Full Text] [Related]
4. Improved bacteriological surveillance of haemodialysis fluids: a comparison between Tryptic soy agar and Reasoner's 2A media.
van der Linde K; Lim BT; Rondeel JM; Antonissen LP; de Jong GM
Nephrol Dial Transplant; 1999 Oct; 14(10):2433-7. PubMed ID: 10528669
[TBL] [Abstract][Full Text] [Related]
5. The antibacterial properties of docosahexaenoic omega-3 fatty acid against the cystic fibrosis multiresistant pathogen Burkholderia cenocepacia.
Mil-Homens D; Bernardes N; Fialho AM
FEMS Microbiol Lett; 2012 Mar; 328(1):61-9. PubMed ID: 22150831
[TBL] [Abstract][Full Text] [Related]
6. Pseudomonas aeruginosa displays an altered phenotype in vitro when grown in the presence of mannitol.
Moore JE; Rendall JC; Downey DG
Br J Biomed Sci; 2015; 72(3):115-9. PubMed ID: 26510267
[TBL] [Abstract][Full Text] [Related]
7. Effects of Extended Storage of Chlorhexidine Gluconate and Benzalkonium Chloride Solutions on the Viability of Burkholderia cenocepacia.
Ahn Y; Kim JM; Lee YJ; LiPuma J; Hussong D; Marasa B; Cerniglia C
J Microbiol Biotechnol; 2017 Dec; 27(12):2211-2220. PubMed ID: 29032643
[TBL] [Abstract][Full Text] [Related]
8. Belfast Agar-a simple laboratory medium to separate Pseudomonas aeruginosa from pan-resistant Burkholderia cenocepacia isolated from the sputum of patients with cystic fibrosis (CF).
Caskey S; Moore JE; McCaughan J; Rendall JC
Br J Biomed Sci; 2018 Apr; 75(2):101-103. PubMed ID: 29513134
[No Abstract] [Full Text] [Related]
9. Survival of Escherichia coli O157:H7 in broth and processed salami as influenced by pH, water activity, and temperature and suitability of media for its recovery.
Clavero MR; Beuchat LR
Appl Environ Microbiol; 1996 Aug; 62(8):2735-40. PubMed ID: 8702265
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of bacteraemia caused by Burkholderia cepacia complex species and antimicrobial susceptibility of the isolates in a medical centre in Taiwan.
Chien YC; Liao CH; Sheng WH; Chien JY; Huang YT; Yu CJ; Hsueh PR
Int J Antimicrob Agents; 2018 Mar; 51(3):357-364. PubMed ID: 28705667
[TBL] [Abstract][Full Text] [Related]
11. Synthetic cystic fibrosis sputum medium diminishes Burkholderia cenocepacia antifungal activity against Aspergillus fumigatus independently of phenylacetic acid production.
Lightly TJ; Phung RR; Sorensen JL; Cardona ST
Can J Microbiol; 2017 May; 63(5):427-438. PubMed ID: 28178425
[TBL] [Abstract][Full Text] [Related]
12. Isolation of Burkholderia cepacia complex genomovars from waters.
Vermis K; Brachkova M; Vandamme P; Nelis H
Syst Appl Microbiol; 2003 Nov; 26(4):595-600. PubMed ID: 14666988
[TBL] [Abstract][Full Text] [Related]
13. Optimization of broth recovery for repair of heat-injured Salmonella enterica serovar Typhimurium and Escherichia coli O157:H7.
Han JY; Song WJ; Kang DH
J Appl Microbiol; 2019 Jun; 126(6):1923-1930. PubMed ID: 30913338
[TBL] [Abstract][Full Text] [Related]
14. Clinical comparison of the recoveries of bloodstream pathogens in Septi-Chek brain heart infusion broth with saponin, Septi-Chek tryptic soy broth, and the isolator lysis-centrifugation system.
Murray PR; Spizzo AW; Niles AC
J Clin Microbiol; 1991 May; 29(5):901-5. PubMed ID: 2056056
[TBL] [Abstract][Full Text] [Related]
15. Comparison of four selective media for the isolation of Burkholderia mallei and Burkholderia pseudomallei.
Glass MB; Beesley CA; Wilkins PP; Hoffmaster AR
Am J Trop Med Hyg; 2009 Jun; 80(6):1023-8. PubMed ID: 19478269
[TBL] [Abstract][Full Text] [Related]
16. Phenylalanine induces Burkholderia cenocepacia phenylacetic acid catabolism through degradation to phenylacetyl-CoA in synthetic cystic fibrosis sputum medium.
Yudistira H; McClarty L; Bloodworth RA; Hammond SA; Butcher H; Mark BL; Cardona ST
Microb Pathog; 2011 Sep; 51(3):186-93. PubMed ID: 21511027
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic Resistance of Burkholderia cepacia Complex to Benzalkonium Chloride.
Ahn Y; Kim JM; Kweon O; Kim SJ; Jones RC; Woodling K; Gamboa da Costa G; LiPuma JJ; Hussong D; Marasa BS; Cerniglia CE
mBio; 2016 Nov; 7(6):. PubMed ID: 27879334
[TBL] [Abstract][Full Text] [Related]
18. Comparison of techniques for culture of dialysis water and fluid.
Maltais JB; Meyer KB; Foster MC
Hemodial Int; 2017 Apr; 21(2):197-205. PubMed ID: 27594052
[TBL] [Abstract][Full Text] [Related]
19. A Pipeline for Screening Small Molecules with Growth Inhibitory Activity against Burkholderia cenocepacia.
Selin C; Stietz MS; Blanchard JE; Gehrke SS; Bernard S; Hall DG; Brown ED; Cardona ST
PLoS One; 2015; 10(6):e0128587. PubMed ID: 26053039
[TBL] [Abstract][Full Text] [Related]
20. Activation of MMP-9 by human lung epithelial cells in response to the cystic fibrosis-associated pathogen Burkholderia cenocepacia reduced wound healing in vitro.
Wright C; Pilkington R; Callaghan M; McClean S
Am J Physiol Lung Cell Mol Physiol; 2011 Oct; 301(4):L575-86. PubMed ID: 21743026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
